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Summary
The diagnosis of osteoporosis based on a T score has in the
literature been slightly different in different countries, partly
depending on the reference population used. This will be
overcome in a WHO project on risk assessment that will cal-
culate the absolute fracture risk based on risk factors includ-
ing BMD. In the cohorts studies this seems to work worldwide. 
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The definition of osteoporosis is a systematic skeletal disease
characterized by low bone mass and micro-architectural deteri-
oration of bone tissue, with a subsequent increase in bone
fragility and susceptibility to fracture (Anonymous, 1993). This
description is both concerning bone mineral density (BMD) and
bone quality, but at present we can only measure BMD. Thus,
the diagnosis of osteoporosis is based solely on a BMD mea-
surement (WHO, 1994). It is also important to separate the op-
erational diagnosis of osteoporosis based on the WHO T score
(WHO, 1994) from intervention thresholds (Kanis et al., 2002a)
since intervention thresholds should be based on the risk of
fracture and the absolute 10 year fracture risk differs markedly
at any given BMD depending mainly on age (Kanis et al.,
2001).
Furthermore, the clinical significance of osteoporosis lies in the
fractures (Johnell et al., 2004a) that arise with their attendant
morbidity and mortality (Johnell et al., 2004b). Low bone mass
is one of the most important component of the risk of fracture,
but other skeletal abnormalities contribute to bone fragility as
well as factors related to falls. Thus, ideally the assessment of
fracture risk should encompass all these aspects of risk (Kanis
et al., 2002b). Also for this reason there is a distinction to be
made between the diagnosis of osteoporosis and the assess-
ment of risk – a distinction between diagnostic and intervention
thresholds (Kanis et al., 2002b).
Low BMD is widely recognized as one of the major risk factors
for fractures (Marshall et al., 1996). Furthermore, BMD mea-
surements at the hip predict hip fractures with a risk that is
comparable to gradient of risk for cardiovascular disease pro-
vided by measurement of blood pressure (Marshall et al.,
1996). Though several studies have been published on frac-
ture risk and BMD we still have several gaps, is BMD working
worldwide, is the threshold the same in men and women, is the
predictive ability similar at different ages etc.?
To clarify whether BMD has a relationship to fracture and if it is
similar worldwide we performed a study based on data from 12
perspective cohort studies that have hip BMD measured, in total
almost 40,000 men and women (Johnell et al., 2005) including
studies from Europe, North America, Asia and Australia. We
calculated the predictive ability of the BMD measurement.
There was no significant difference between the cohorts after
adjustment for age – thus no heterogeneity. The 12 perspective
cohorts – both men and women – were followed for 168,000
person years with almost 1,000 hip fractures and 2,600 osteo-
porotic fractures. The predictive ability was only marginally dif-
ferent between men and women and not statistically significant
(Johnell et al., 2005). There was an effect of age in that the gra-
dient of risk was not the same in all ages. For hip fracture the
gradient of risk was highest at the lowest ages and low at the
highest ages. The implication of these findings is that is better
to use BMD in young ages than in old ages (Johnell et al.,
2005). There was a small attenuation of the gradient of risk with
time after assessment for hip fractures, but not significant.
There was also a tendency that the gradient of risk per SD de-
crease in BMD for hip fractures decreased with increasingly bet-
ter Z score, thus there was a non-significant better predictive
ability of fractures in those with low BMD (Johnell et al., 2005). 
In this study also ultrasound and peripheral measurements
were tested (Johnell et al., 2005). The predictive ability for hip
fractures was lower than for hip BMD but there was a signifi-
cant predictive effect of both ultrasound and peripheral mea-
surements. 
In a separate calculation differences in prediction of hip frac-
ture were studied (O. Johnell and J.A. Kanis, personal commu-
nication), whether lumbar spine BMD measurement had the
same predictive ability as femoral neck BMD measurement and
if the combination of femoral neck BMD and lumbar spine BMD
could increase the predictive ability. The data show that for hip
fracture BMD at the hip had a better predictive ability than the
lumbar spine measurements and that combination of lumbar
spine BMD and femoral neck BMD did not contribute to an in-
creased predictive ability.
The problem with BMD is also that the absolute values differ
between the types of scanner but an algorithm has been creat-
ed to get a standardized BMD for the different scanners (Kanis
et al., 2002b). This is necessary to make an easy calculation
for the T score. As mentioned earlier, the diagnosis and the in-
tervention threshold should be divided (Kanis et al., 2002b).
Therefore focus on risk assessment for intervention threshold
with BMD measurements and other risk factors should be
done. The prevalence of osteoporosis is somewhat different in
the published studies in that there are more osteoporotic pa-
tients in some countries, partly depending on the reference
population, whether it is from the local area or from the manu-
facturer. Therefore we should shift focus from the diagnosis to
risk assessment. From the studies quoted this seems to work
worldwide (Johnell et al., 2005).
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A WHO project on risk assessment is almost finished and a
technical report will soon be published, where risk assessment
is based on health economically determined cut offs with ab-
solute fracture risk. There are several clinical risk factors that
can be used in risk assessment but they have to be validated
in multiple populations, adjusted for age, sex and type of frac-
ture, readily assessable by primary care physicians, contribute
to a risk that is amenable to the therapeutic manipulation in-
tended, intuitive rather than counterintuitive to medical care
(Kanis et al., 2002b). A cornerstone of the clinical risk factor is
a BMD measurement but also other risk factors have to be
added to BMD. The predictive ability of BMD + clinical risk fac-
tors is much better than clinical risk factors only. If there is a
possibility to use BMD worldwide more patients at high risk will
be identified by using a BMD measurement.
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